Results 121 to 130 of about 12,752 (178)

In vitro and in vivo studies on the activity and selectivity of butoconazole in experimental infection by Trypanosoma cruzi. [PDF]

Mem Inst Oswaldo Cruz
Leite GR, Batista DDGJ, Batista MM, da Costa KN, Loughlin TM, Barrionuevo EM, Talevi A, Aberca LN, Moreira OC, Faier-Pereira A, Ferreira BIDS, Soeiro MNC.   +11 more
europepmc   +1 more source

Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound. [PDF]

Pharmaceuticals (Basel)
Bethencourt-Estrella CJ, López-Arencibia A, Calero-Docina IM, Fuchs F, Scheid P, Lorenzo-Morales J, Piñero JE.   +6 more
europepmc   +1 more source

Synthesis and Evaluation of a Hybrid Miltefosine-Silver Nanoparticle Complex: Synergistic Interaction with Benznidazole Against Trypanosoma cruzi. [PDF]

Acta Parasitol
Özel Y, Çavuş İ, Tokay F, Bağdat S, Özbilgin A.   +4 more
europepmc   +1 more source

Effect of <i>Euterpe oleracea</i> Mart. (Açaí) Seed Bioproducts on <i>Trypanosoma cruzi</i>. [PDF]

Biology (Basel)
Previtalli-Silva H, Hardoim DJ, Banaggia RL, Moragas-Tellis CJ, Souza PVR, Behrens MD, Silva TSD, Calabrese KDS, Cardoso FO.   +8 more
europepmc   +1 more source

Trypanocidal Treatment for Chronic Chagas Disease: Past, Present, and Future. [PDF]

Rev Soc Bras Med Trop
Hasslocher-Moreno AM.
europepmc   +1 more source

Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection. [PDF]

PLoS Negl Trop Dis
Forsyth C, Garcia-Bournissen F, Moscatelli G, Moroni S, Pereiro A, Ortiz-Daza L, Cuevas EH, Tinajeros F, Marques T, Marchiol A, Herazo R, Seu S, Sancho J, Altcheh J, Pinazo MJ.   +14 more
europepmc   +1 more source

Case Report: Donor-derived Chagas Disease Post-heart Transplant After False-negative Donor <i>Trypanosoma cruzi</i> Testing. [PDF]

Transplant Direct
Mihori M, Bryson A, Doern C, Farhat F, Lai G, Mochel M, Morales MK, Smallfield M, Tchoukina I, Vissichelli NC.   +9 more
europepmc   +1 more source

Benznidazole Treatment

As the development of new drugs for Chagas disease is not a priority due to its neglected disease status, an option for increasing treatment adherence is to explore alternative treatment regimens, which may decrease the incidence of side effects. Therefore, we evaluated the efficacy of different therapeutic schemes with benznidazole (BNZ) on the acute ...
Fonseca, Kátia da Silva, Perin, Luísa, de Paiva, Nívia Carolina Nogueira, da Silva, Beatriz Cristiane, Duarte, Thays Helena Chaves, Marques, Flávia de Souza, Costa, Guilherme de Paula, Molina Romero, Israel||, Correa-Oliveira, Rodrigo||, Vieira, Paula Melo de Abreu||, Carneiro, Cláudia Martins||   +10 more
openaire   +1 more source

Drugs for 'neglected diseases': a bitter pill. [PDF]

, 2000
Pécoul, B, Veeken, H
core   +1 more source

Cytosporone B Affects ATP Production of <i>Trypanosoma cruzi</i>: A Lethal Action Investigation. [PDF]

ACS Omega
Dos Santos AL, Amaral M, de Castro Levatti EV, Romanelli M, Pena Ferreira MJ, Tempone AG, Sartorelli P.   +6 more
europepmc   +1 more source